Repligen (RGEN) Promotes CCO, Shares Fall on Leadership Change [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
The company's current CEO, Tony J. Hunt, will step down from his role and will transition to executive chair with effect from Sep 1, 2024. Shares of RGEN fell 11.9% on Jun 13 following the announcement of the news. Olivier Loeillot joined Repligen as president and CCO in October last year. Prior to joining Repligen, he held senior positions at GE Healthcare Life Sciences and served as the Bioprocess President at Cytiva (a Danaher company). He has also held senior positions at Lonza. Shares of Repligen have plunged 30% so far this year compared with the industry's decline of 5.2%. Image Source: Zacks Investment Research Tony J. Hunt has been a member of RGEN's board of directors and has served as CEO since May 2015. Under his leadership, the company witnessed above-industry growth through innovative product development, mergers and acquisitions and proper commercial execution. During his tenure, Repligen's total revenues witnessed an annual growth rate of more than 30% ove
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- The Schall Law Firm Begins Investigation Into Claims Against Regeneron Pharmaceuticals Inc And Encourages Affected Investors To Contact ThemAccesswire
- What Is Repligen Corporation's (NASDAQ:RGEN) Share Price Doing? [Yahoo! Finance]Yahoo! Finance
- Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock.MarketBeat
- Repligen Announces CEO Transition Plan [Yahoo! Finance]Yahoo! Finance
- Repligen Announces CEO Transition PlanGlobeNewswire
RGEN
Earnings
- 5/1/24 - Miss
RGEN
Sec Filings
- 6/14/24 - Form 4
- 6/14/24 - Form 4
- 6/14/24 - Form 4
- RGEN's page on the SEC website